Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
Gilead Sciences, Inc. Heart Drug Disappoints, Program Likely Dropped; Company Says Pivotal Phase of Study Missed Main Goals
Biospace
Gilead Sciences, Inc. (GILD 12/15/2009 FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. Full Article at Biospace
-
The irony of a failed blood pressure drug is that it can raise the blood pressure of the folks who pushed for its development. Full Article at Pharmalot
-
Gilead Sciences Inc. headquarters in Foster City, Calif. , is seen Thursday, March 12, 2009. View Photo »
-
Three years after UNITAID broached the [patent pool] idea, it says that so far only Gilead Sciences, Johnson & Johnson and Merck are 'actively engaged' in negotiating with UNITAID over the patent pool. Since February UNITAID has been lobbying 9 other drugmakers and 17 generics manufacturers to sit down ...
SOURCE: Medical News Today -
LONDON -- Gilead Sciences Inc. said Tuesday that a Phase III clinical trial evaluating darusentan did not achieve its co-primary efficacy endpoints of achieving a change in systolic and diastolic blood pressure after 14 weeks compared to a placebo. Full Article at FOX News
-
LONDON (MarketWatch) -- Gilead Sciences Inc. Full Article at MarketWatch
-
Gilead Sciences (Gilead) has reported that DAR-312 (DORADO-AC), a Phase III clinical trial evaluating darusentan did not achieve its co-primary efficacy endpoints of change from baseline to week 14 in trough sitting systolic blood pressure (SBP) and... Full Article at Pharmaceutical Business Review
-
In this Jan. 28, 2009 file photo, the exterior of CV Therapeutics headquarters in Palo Alto, Calif. is shown. View Photo »
-
Britain's Health Protection Agency (HPA) said five cases have been confirmed in Wales of patients infected with H1N1 resistant to oseltamivir - the generic name of Roche and Gilead Sciences Inc's antiviral drug Tamiflu
SOURCE: Medical News Today -
-
Second Pivotal Phase III Study of Gilead’s Darusentan for Resistant Hypertension Misses Primary Endpoints
PR-Inside.com
2009-12-15 01:44:34 - Phase III double-blind, placebo- and active-controlled, parallel group trial, in which 849 patients were randomized to receive darusentan (titrated to the optimal dose of 50, 100 or 300 mg once daily), an active... Full Article at PR-Inside.com
-
Forbes examines the ongoing discussions between aid groups and drug manufacturers over the formation of an HIV/AIDS drugs patent pool to help drive down costs for developing countries. Full Article at Medical News Today
About Gilead Sciences, Inc.
Wikipedia
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Related Photos
prev
next
-
AP Photo
Gilead Sciences Inc. headquarters in Foster City, Calif. , is seen Thursday, March 12, 2009. Biotechnology company Gilead Sciences Inc. said Thursday it will buy CV Therapeutics for about $1.4 billion as a wave of consolidation in the drug industry continues.
View Photo » -
AP Photo
In this Jan. 28, 2009 file photo, the exterior of CV Therapeutics headquarters in Palo Alto, Calif. is shown. Biotechnology company Gilead Sciences Inc. said Thursday it will buy CV Therapeutics for about $1.4 billion as a wave of consolidation in the drug industry continues.
View Photo » -
AP Photo
In this Jan. 28, 2009 file photo, the exterior of CV Therapeutics headquarters in Palo Alto, Calif. is shown. Biotechnology company Gilead Sciences Inc. said Thursday it will buy CV Therapeutics for about $1.4 billion as a wave of consolidation in the drug industry continues.
View Photo »
AP Photo
In this Jan. 28, 2009 file photo, the exterior of CV Therapeutics headquarters in Palo Alto, Calif. is shown. Biotechnology company Gilead Sciences Inc. said Thursday it will buy CV Therapeutics for about $1.4 billion as a wave of consolidation in the drug industry continues.
View Photo »Related Topics
Related Videos
Related Conversations
There are no results for this module. Edit the module to change the search term used to query Twitter.